DNA vaccination is highly efficient at inducing CD8(+) T cell responses in
animal models. Here we investigated whether DNA vaccine technology could be
exploited to identify subdominant cytotoxic T lymphocytes (CTL) epitopes.
Previous studies have shown that the Sendai virus HN protein does not induc
e a CD8(+) T cell response in C57BL/6 mice. Thus, we vaccinated C57BL/6 mic
e with a DNA vaccine encoding Sendai virus hemagglutinin neuraminidase (HN)
protein. The data show that this strategy elicited a potent D-b-restricted
CD8(+) CTL response against at least one subdominant HN-derived epitope. T
hese CTL were able to lyse Sendai virus-infected target cells, demonstratin
g that the epitope was appropriately processed and present at sufficient le
vels for T cell recognition. However, these cells did not confer protection
against lethal challenge with Sendai virus. These data demonstrate the cap
acity of DNA vaccine to raise CTL responses to subdominant epitopes, but sh
ow that such responses may be limited in their efficacy against non-persist
ent viruses. (C) 1999 Elsevier Science Ltd. All rights reserved.